Engrail Therapeutics
Signal active
Organization
Contact Information
Overview
Engrail is forging a new direction to reduce the enormous burden of diseases that impact the nervous system. We unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverage our flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization.
About
Industries
Life Science, Health Care, Pharmaceutical, Medical
Founded
2019
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Engrail Therapeutics headquartered in United States, North America, operates in the Life Science, Health Care, Pharmaceutical, Medical sector. The company focuses on Life Science and has secured $10.6B in funding across 48 round(s). With a team of 1-10 employees, Engrail Therapeutics is actively contributing to advancements in Life Science. Their latest funding round, Series B - Engrail Therapeutics, raised $157.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
10
Lead Investors
0
Total Funding Amount
$221.0M
Details
3
Engrail Therapeutics has raised a total of $221.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 32.0M | ||
| 2021 | Early Stage Venture | 32.0M | ||
| 2024 | Early Stage Venture | 157.0M |
Investors
Engrail Therapeutics is funded by 20 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Red Tree Venture Capital | - | FUNDING ROUND - Red Tree Venture Capital | 157.0M |
| Ysios Capital | - | FUNDING ROUND - Ysios Capital | 157.0M |
| Engrail Therapeutics | - | FUNDING ROUND - Engrail Therapeutics | 157.0M |
| Abrdn | - | FUNDING ROUND - Abrdn | 157.0M |
Recent Activity
There is no recent news or activity for this profile.